Meglumine antimoniate indications and usage
| Meglumine Antimoniate |
|---|
| GLUCANTIM® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications and Usage
Treatment of:
• visceral leishmaniasis • cutaneous leishmaniasis (except for L. aethiopica infections, which are unresponsive) • diffuse cutaneous leishmaniasis due to L. amazonensis • cutaneous and mucocutaneous leishmaniasis due to L. braziliensis.
References
Adapted from the FDA Package Insert.